Holen Sie sich die Stockscreener-App
11.78
4.62%
-0.57
Handel nachbörslich:
11.78
Schlusskurs vom Vortag:
$12.35
Offen:
$12.5
24-Stunden-Volumen:
51,545
Relative Volume:
0.99
Marktkapitalisierung:
$157.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.89M
KGV:
-16.83
EPS:
-0.7
Netto-Cashflow:
$-6.48M
1W Leistung:
-2.64%
1M Leistung:
+8.67%
6M Leistung:
-4.23%
1J Leistung:
-13.83%
1-Tages-Spanne:
$11.78
$12.70
1-Wochen-Bereich:
$11.44
$12.88
52-Wochen-Spanne:
$8.06
$16.50
Greenwich Lifesciences Inc Stock (GLSI) Company Profile
Firmenname
Greenwich Lifesciences Inc
Sektor
Branche
Telefon
203-434-3290
Adresse
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Vergleichen Sie GLSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLSI
Greenwich Lifesciences Inc
|
11.78 | 166.97M | 0 | -8.89M | -6.48M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-09-01 | Eingeleitet | H.C. Wainwright | Buy |
Greenwich Lifesciences Inc Aktie (GLSI) Neueste Nachrichten
How to build a dashboard for Greenwich LifeSciences Inc. stockEarnings Beat & Accurate Technical Buy Alerts - Newser
Predicting Greenwich LifeSciences Inc. trend using moving averages2025 Trade Ideas & Expert Verified Stock Movement Alerts - Newser
Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania - GlobeNewswire
Greenwich LifeSciences expands phase III breast cancer trial to Romania - Investing.com
Greenwich LifeSciences Targets 12,800 Annual Breast Cancer Cases with Romanian Trial Expansion - Stock Titan
Can Greenwich LifeSciences Inc. hit a new high this month2025 Market Outlook & Daily Stock Trend Watchlist - Newser
How Greenwich LifeSciences Inc. stock performs during market volatility2025 Short Interest & Real-Time Volume Trigger Notifications - Newser
Why Greenwich LifeSciences Inc. stock attracts strong analyst attentionWatchlist Summary for Active Day Traders - Newser
Is Greenwich LifeSciences Inc. forming a reversal patternTrade Safety Matrix for Conservative Traders - Newser
Sectors Driving Future Growth for Galecto Inc. StockFree Safe Entry Stock Watch Suggestions - Newser
Greenwich LifeSciences (NASDAQ:GLSI) Stock Price Up 2.5% – Still a Buy? - Defense World
Is Greenwich LifeSciences Inc. a defensive stockFree Smart Money Flow Analysis - newsyoung.net
Forecasting Greenwich LifeSciences Inc. price range with options dataSwing Trade Entry and Exit Point Analysis - Newser
Greenwich LifeSciences Updates CEO Interviews and Key Events, Presents Flamingo-01 Trial Data at Major Conferences. - AInvest
What indicators show strength in Greenwich LifeSciences Inc.Technical Trade Plan with Entry Checklist - Newser
Greenwich LifeSciences Updates CEO Interviews, Corporate Events Schedule. - AInvest
Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events - The Manila Times
Greenwich LifeSciences Showcases Breast Cancer Breakthrough Across Major Financial Networks - Stock Titan
Can Greenwich LifeSciences Inc. rally from current levelsLong-Term Allocation Strategy Summary Breakdown - Newser
What earnings revisions data tells us about Greenwich LifeSciences Inc.Real Stock Picks With Setup Verification - Newser
Using AI based signals to follow Greenwich LifeSciences Inc.Profitable Trading Blueprint with Entry Zones - Newser
Published on: 2025-08-11 00:07:13 - Newser
Chart based exit strategy for Greenwich LifeSciences Inc.Summary of Consistent Growth Stock Picks - Newser
What’s next for Greenwich LifeSciences Inc. stock priceFree High Accuracy Alerts for ROI Traders - Newser
How to read the order book for Greenwich LifeSciences Inc.Free Low Risk Picks for Daily Trading - Newser
Ranking FORM among high performing stocks via toolsLong Term Stock Planner with Safety Checks - Newser
What drives Greenwich LifeSciences Inc. stock priceMaximize your returns with portfolio optimization - Jammu Links News
What analysts say about Greenwich LifeSciences Inc. stockMaximize your portfolio’s growth potential - Jammu Links News
What are the technical indicators suggesting about Greenwich LifeSciences Inc.Unrivaled growth potential - Jammu Links News
What are the latest earnings results for Greenwich LifeSciences Inc.Maximize gains with data-driven stock picks - Jammu Links News
How does Greenwich LifeSciences Inc. generate profit in a changing economyFree Advanced Stock Screener Access - Jammu Links News
Greenwich LifeSciences Inc. stock prediction for this weekTechnical Reversal Pattern Summary and Tracker - Newser
Why is Greenwich LifeSciences Inc. stock attracting strong analyst attentionDynamic growth stocks - Jammu Links News
What institutional investors are buying Greenwich LifeSciences Inc. stockBoost your wealth with consistent growth stocks - Jammu Links News
What catalysts could drive Greenwich LifeSciences Inc. stock higher in 2025Invest confidently with data-driven strategies - Jammu Links News
Finanzdaten der Greenwich Lifesciences Inc-Aktie (GLSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Greenwich Lifesciences Inc-Aktie (GLSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Patel Snehal | CEO and CFO |
Apr 17 '25 |
Buy |
8.98 |
5,400 |
48,492 |
5,567,002 |
| Patel Snehal | CEO and CFO |
Apr 07 '25 |
Buy |
9.10 |
3,600 |
32,760 |
5,561,602 |
| Patel Snehal | CEO and CFO |
Apr 04 '25 |
Buy |
8.73 |
5,500 |
48,015 |
5,558,002 |
| Patel Snehal | CEO and CFO |
Jan 10 '25 |
Buy |
12.51 |
2,500 |
31,275 |
5,552,502 |
| Patel Snehal | CEO and CFO |
Jan 07 '25 |
Buy |
13.75 |
1,800 |
24,750 |
5,550,002 |
| Patel Snehal | CEO and CFO |
Jan 06 '25 |
Buy |
13.31 |
1,100 |
14,641 |
5,548,202 |
| Patel Snehal | CEO and CFO |
Jan 03 '25 |
Buy |
12.95 |
3,400 |
44,030 |
5,547,102 |
| Patel Snehal | CEO and CFO |
Jan 02 '25 |
Buy |
11.97 |
2,000 |
23,940 |
5,543,702 |
| Patel Snehal | CEO and CFO |
Dec 31 '24 |
Buy |
11.36 |
2,400 |
27,264 |
5,541,702 |
| Patel Snehal | CEO and CFO |
Dec 30 '24 |
Buy |
11.12 |
3,200 |
35,584 |
5,539,302 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):